Osborne Clarke and Proskauer Rose advised Grifols on the deal, and Cravath Swaine & Moore advised the placement agent.Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
